September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...

September 11, 2017 — Researchers have led a retrospective single-center study examining simple hemodynamic parameters ...

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late ...

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of ...
September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System ...
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience dr ...
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advances ...
August 31, 2017 — Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial ...

August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI. The ...
August 31, 2017 — NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid ...